Stryker

220 articles with Stryker

• Stryker’s AxSOS 3® Ankle Fusion System Offers Innovative Plates That Are Designed to Fit a Range of Patients

  9/1/2020

  Stryker’s AxSOS 3 ® Ankle Fusion System Offers Innovative Plates That Are Designed to Fit a Range of Patients New System Includes Titanium Plates with Streamlined Instrumentation and Updated Screw Offerings MAHWAH, N.J.--( BUSINESS WIRE )-- Stryker’s Trauma & Extremities division today announced the launch of its AxSOS 3 Ankle Fusion System, an ankle fusion titanium plate system intended for the fusion of the tibio-talar joint. This press rele

• Stryker's Neuroform Atlas® Stent System granted an expanded indication, providing a new option for patients with aneurysms in the back of the brain

  8/3/2020

   Stryker announced today that it has received U.S. Food and Drug Administration (FDA) approval for an expanded indication of its Neuroform Atlas Stent System, becoming the first and only adjunctive stent approved for use in the posterior (back of the brain) circulation.   Aneurysms in the posterior circulation rupture more

• Stryker reports second quarter 2020 operating results

  7/30/2020

  Stryker (NYSE:SYK) reported operating results for the second quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally, including the postponement of deferrable medical procedures and social contact restrictions, which have had a significant negative impact on Stryker’s operations and financial results. Secon

• Stryker declares a $0.575 per share quarterly dividend payable October 30, 2020

  7/30/2020

  Stryker announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable October 30, 2020 to shareholders of record at the close of business on September 30, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.

• Stryker extends cash tender offer for all outstanding shares of Wright Medical - June 29, 2020

  6/29/2020

  Stryker announced that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V.

• Stryker to host conference call on July 30, 2020

  6/25/2020

  Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, July 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2020 and provide an operational update. Final operating results for the quarter ended June 30, 2020 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (international) and

• Stryker announces pricing of $2.3 billion senior notes offering

  5/26/2020

  Stryker announced that it has priced the following senior notes: $650 million aggregate principal amount of the Company’s 1.150% Notes due 2025, $1 billion aggregate principal amount of the Company’s 1.950% Notes due 2030, and $650 million aggregate principal amount of the Company’s 2.900% Notes due 2050.

• Stryker declares a $0.575 per share quarterly dividend payable on July 31, 2020

  5/5/2020

  Stryker announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on July 31, 2020 to shareholders of record at the close of business on June 30, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.

• Stryker reports first quarter 2020 operating results

  4/30/2020

  The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally, including the deferral of elective medical procedures and social contact restrictions, which have had a significant negative impact on Stryker’s operations and financial results.

• Stryker extends cash tender offer for all outstanding shares of Wright Medical - April 27, 2020

  4/27/2020

  Stryker announced that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V..

• 

  Biopharma Update on the Novel Coronavirus: April 16

  4/16/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.

• Stryker to host conference call on April 30, 2020

  4/9/2020

  Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2020 and provide an operational update

• Stryker announces Annual Meeting of Shareholders

  3/24/2020

  Stryker (NYSE:SYK) announced its 2020 Annual Meeting of Shareholders is scheduled as follows:

• Stryker announces new Investor Relations leader

  3/2/2020

  Stryker announced that Preston Wells will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective June 1, 2020.

• Stryker extends cash tender offer for all outstanding shares of Wright Medical

  2/26/2020

  Stryker announced that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V.

• Stryker to participate in Cowen 40th Annual Health Care Conference

  2/25/2020

  Stryker (NYSE:SYK) ) will participate in the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020 at the Boston Marriott Copley Place in Boston, Massachusetts. 

• Stryker announces nomination of new Director, Lisa Skeete Tatum

  2/25/2020

  Stryker announced that Lisa Skeete Tatum has been nominated for election to the company’s Board of Directors at Stryker’s 2020 Annual Meeting of Shareholders, which will be held on May 5, 2020.

• Stryker named to the 100 Best Companies to Work For list for 10th consecutive year

  2/18/2020

  Stryker, one of the world’s leading medical technology companies, announced it has been named one of Fortune’s 2020 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States for a 10th consecutive year.

• Stryker declares a $0.575 per share quarterly dividend

  2/5/2020

  Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on April 30, 2020 to shareholders of record at the close of business on March 31, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter. 

• Wright Medical Group N.V. Announces Definitive Agreement to be Acquired by Stryker

  11/4/2019

  Purchase Price of $30.75 Per Share in Cash; Total Enterprise Value of Approximately $5.4 Billion and Total Equity Value of Approximately $4.7 Billion